The United States: Flawless Beauty, LLC issues voluntary recall of unapproved drugs (English Only)
 
The US Food and Drug Administration (FDA) announces that Flawless Beauty, LLC is voluntarily recalling all lots of the following products sold individually or as part of multi-unit kits alleged by the FDA to be misbranded or unapproved new drugs pursuant to the Federal Food, Drug, and Cosmetic Act. The FDA believes that these drugs present serious public health risks. To date, Flawless Beauty has not received any reports of adverse events related to this recall. 

The following products are subject to the recall and were sold and distributed over the Internet to US and foreign customers. The website of Flawless Beauty is www.flawlessbeautyandskin.com. All glutathione products were sold in multi-vial whitening kits, either alone or in combination with ampules of vitamin C and sterile water. Vials or ampules of vitamin C or sterile water purchased separately or as part of these whitening kits are also recalled: 
- Relumins Advanced Glutathione kits w/ 900mg vials 
- Relumins Advanced Glutathione kits w/ 1500mg vials 
- Relumins Advanced Glutathione kits w/ 3000 vials 
- Relumins Vitamin C Solvent ampules 
- Tatiomax Gluatathione Whitening kits w/ 1400mg vials 
- Saluta Glutathione Whitening kits w/ 600mg vials 
- Saluta Glutathione Whitening kits w/ 1200mg vials 
- Saluta Glutathione Whitening kits w/ 1800mg vials 
- Laroscorbine Platinum Vitamin C with Collagen – 1100mg 
- Tationil Glutathione Whitening 10 vial kits 
- Tationil Glutathione Whitening (5 sets of 10 vial kits) 
- Laennec Human Placenta Whitening kits – 2ml vials 
- Reiki Glutathione Whitening kits 
- TAD Glutathione Whitening kits w/ 600mg vials 
- TP Drug Laboratories Vitamin C ampules 
- Sterile water ampules 
- Ling Zhi capsules 

Please refer to the following website in FDA for details: http://www.fda.gov/Safety/Recalls/ucm593149.htm 

In Hong Kong, the above products are not registered pharmaceutical products. 

Ends/Tuesday, Jan 23, 2018 
Issued at HKT 15:00 

轉載自衛生署藥物辦公室網頁http://www.drugoffice.gov.hk/